BI-749327
CAS No. 2361241-23-6
BI-749327 ( —— )
Catalog No. M24070 CAS No. 2361241-23-6
BI-749327 is a high selectivity and orally bioavailable antagonist of TRPC6 (IC50s: 13 nM, 19 nM and 15 nM for mouse, human and guinea pig TRPC6).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 260 | In Stock |
|
10MG | 410 | In Stock |
|
25MG | 678 | In Stock |
|
50MG | 954 | In Stock |
|
100MG | 1287 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI-749327
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI-749327 is a high selectivity and orally bioavailable antagonist of TRPC6 (IC50s: 13 nM, 19 nM and 15 nM for mouse, human and guinea pig TRPC6).
-
DescriptionBI-749327 is a high selectivity and orally bioavailable antagonist of TRPC6 (IC50s: 13 nM, 19 nM and 15 nM for mouse, human and guinea pig TRPC6).
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
Recptormouse TRPC6;human TRPC6;guinea pig TRPC6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2361241-23-6
-
Formula Weight442.4
-
Molecular FormulaC23H21F3N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL (70.63 mM; Need ultrasonic)
-
SMILESNC1=NN=C(C2CCN(C(C3=CC=C(OC4=CC=C(C(F)(F)F)C=C4)C=C3)=O)CC2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lin B L, et al. In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease. Proc Natl Acad Sci U S A. 2019 May 14;116(20):10156-10161.
molnova catalog
related products
-
JNJ-38893777
JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
-
Olvanil
Olvanil is a vanilloid receptor agonist with EC50 of 0.7nM.
-
Palvanil
Palvanil is a fast desensitizing agonist of TRPV1. it may be promising agents in the therapy of IBS since it modulates intestinal motility and reduces visceral pain.